IL1B and rheumatoid arthritis: Increased NLRP3 expression and activation, together with the release of IL-1β, has been linked to pathogenesis of several painful inflammatory and non-inflammatory conditions such as rheumatoid arthritis, gout, neuropathic pain and diabetic wound healing (Table 1).